InvestorsHub Logo
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Re: docj post# 11387

Saturday, 02/29/2020 12:47:25 PM

Saturday, February 29, 2020 12:47:25 PM

Post# of 14684
Thanks doc will b added to the I-Box. Watching this and other companies and adjusting my portfolio this week. Bought more Fri on top of what I was holding.

Just added this: Finally: I don't think many day traders and particularly short sellers realize what they have gotten themselves into. Any day now there will be news of significance such as the NGIO spinout and valuation details. Aside from cancer research and the rest, GNBT/NGIO is in position number one for a coronavirus vaccine in China. They are about to sign a nice deal with upfront money which is sufficient to get the initial work done in all likelihood. Milestone payment, all the costs covered and 20% of the rev's. NGIO's vaccine technology is such that it can be ready faster than traditional vaccines and can be produced in huge volumes very fast. A successful vaccine will result in an tremendous revenue revenue stream and big pharma looking at NGIO as a buy out candidate. A coronavirus vaccine is worth billions worldwide if this disease becomes an annual contagion as many medical researchers believe.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.